ESG

Chetu webinar to guide leaders on navigating AI implementation, modernizing legacy systems, and improving patient outcomes through real-world strategies.

A major Singaporean laundry provider cuts its carbon footprint by 24% by switching to LNG, a move signaling a broader industrial shift to cleaner energy.

Global reinsurer SCOR SE wins unanimous shareholder approval for all resolutions, raising its dividend and signaling confidence amid a shifting market.

As South Korea's demand for high-protein foods soars, European poultry producers are making a strategic play, banking on high quality and safety standards.

Sorenson Impact Advisory absorbs top talent from the closing Align Impact, uniting industry pioneers to create a new giant in mission-driven finance.

The pharma giant reports a net loss after a major write-down, but management points to a strong consumer division and a CDMO rebound as signs of recovery.

The Aesthetic Show returns to Vegas, blending AI and regenerative science with a focus on inclusivity, professional growth, and philanthropic purpose.

A new federal initiative aims to eliminate paper forms in clinics, giving patients control over their health data with a simple QR code. Here's how it works.

With a fresh $11.5M Series A, Clarasight is using AI to unify fragmented travel and expense data, promising massive savings for global enterprises.

A new cell-free therapy, Ultrasome™, shows a 93% response rate in a pilot study, offering a scalable, regenerative solution for millions with knee pain.

Camber's new service model guarantees 98% EV charger uptime for fleets, automatically waiving fees if performance falls short. Is this the new standard?

Terminix's new podcast reframes pest management from a reactive chore to a core business strategy, empowering leaders to mitigate operational and financial risks.

A startup's novel 4D mammography system completes its first human trial, promising to detect cancer's molecular fingerprint and slash false positives.

A new HHS agenda reopens the door for controversial peptides, just as a wave of next-gen obesity drugs threatens to upend the entire market.

A new wearable using ultrasound resonance could finally solve the accuracy and calibration problems plaguing blood pressure monitors for a billion patients.

An $850M deal for an Arizona cobalt plant marks a pivotal US-Japan move to secure supply chains for defense, EVs, and advanced tech from rivals.

With a massive Series A, Coultreon Biopharma is advancing a novel SIK3 inhibitor spun out of Galapagos to rival injectable blockbusters for autoimmune disease.

Strong performance in its Materials Group helped Avery Dennison surpass Q1 earnings, offsetting a slight downturn in its strategic Intelligent Labels division.

BRC Therapeutics gets the FDA green light for BRC-002, a novel cannabinoid drug for CRPS, a severe pain condition with no approved US treatments.

Discover the cutting-edge tech behind the silent, zero-emission garbage truck transforming waste management and helping cities meet climate goals.